Head-to-head · WeighScore
CoreAge Rx vs Prime Doctor RX
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 73/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Prime Doctor RX |
|---|---|---|
| WeighScore | 89.5/100 | 73/100 |
| Grade | B+ | C |
| Site position | #1 | #82 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | $249 every 4 weeks (thirteen charges a year, not twelve) |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | $339 every 4 weeks (thirteen charges a year, not twelve) |
| Coverage | US only; therapy-specific state restrictions apply | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
Site position #82 · C
Strengths
- The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
- The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
- The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
- Names OpenLoop Health as the group providing telehealth evaluation and prescribing
- Hormone-care initial labs are priced at $50 rather than left unstated
What to consider
- Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
- A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
- The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
- The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
- The $50 lab fee sits in a "how it works" step rather than in the pricing table
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.